VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / Sativa Wellness Group Inc. (OTC PINK:SCNNF)(CSE:SWEL) ("Sativa Wellness" or the "Company") wishes to announce Sativa Wellness expanding COVID Testing Clinic to Bristol Goodbody Wellness Store as a result of the significant success of the launch of COVID testing capabilities at the Bath Goodbody Wellness store.
As a result of the significant success of the launch of COVID testing capabilities at our Goodbody Wellness store in Bath, we have expanded the service to our Goodbody Wellness Bristol store.
The in- store clinic provides PCR testing for travel and work, quick antigen testing as well as antibody testing to indicate if antibodies are present.
Our Goodbody Wellness stores help customers with our full range of our CBD wellness products and now feature this testing capability along with a range of hand sanitiser products.
The UK has come out of the recent lockdown but is still battling the COVID 19 pandemic, with tiered restrictions in place nationwide. The holiday season is driving demand for travel and measures are in place to identify, track and trace any positive cases. A large number of countries require a negative COVID PCR test prior to travel. In addition, from December 15th the UK government has introduced a "Test to Release" scheme to reduce the quarantine period for travellers returning to the UK with a negative COVID test, to a minimum of five days after return from a location not on the travel corridor list.
"We are seeing a very strong demand for the new clinic's testing capabilities. As the holidays approach, university students depart and people travel abroad to go home or visit relatives, the demand for safe travel is escalating rapidly. Our Goodbody Wellness stores and clinics help people at this challenging time. We will continue to look for more opportunities to expand this service.", stated Henry Lees-Buckley CEO Sativa Wellness Group.
About the Tests
Our private clinics are designed for people who aren't presenting symptoms but who need a negative test for travel, work or peace of mind when visiting vulnerable relatives. Anyone with symptoms should instead book an NHS test and follow the Government isolation procedures.
The PCR lab test is a swab sent for analysis at an accredited laboratory to test for the presence of COVID-19 and costs £155. A certificate delivered direct via email and SMS is provided to permit travelling and pass immigration. The test is 98% sensitive if the virus is found on the swab and has a 48-72-hour turnaround.
A rapid antigen test is also available which checks whether you are carrying the COVID-19 virus and could be infectious to others. Sensitivity is 92.5% and Specificity is 99.8%. Results are available in 15 minutes and the test costs £75.
Finally, an IgG and IgM rapid antibody test costing £55 is available which tests to see if you have already had COVID-19 and have developed antibodies. The test has an accuracy of 98.3% and results are available in just 15 minutes.
For more information or to book an appointment visit https://www.goodbodyclinic.com
Further information regarding the Company can be found under the Company's profile on www.sedar.com.
On behalf of the Board of Directors,
Henry Lees-Buckley
Chief Executive Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc.
jason@sativawellnessgroup.com
www.sativawellnessgroup.com
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the success of the launch of COVID testing capabilities at the Bath Goodbody Wellness store, the expansion of COVID testing capabilities in the Goodbody Wellness Bristol store, the relevant government restrictions due to COVID, the factors driving demand for COVID tests, the applicability of the Company's COVID test for travel, work or peace of mind, and the test accuracy and timing of any test results.
Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that the Company will launch expanded testing COVID testing facilities and that the Company will be successful in capitalizing on the demand for COVID tests. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
SOURCE: Sativa Wellness Group Inc.
View source version on accesswire.com:
https://www.accesswire.com/619862/Sativa-Wellness-Expands-COVID-Testing
